Blog

News July 20, 2021

PEP-Therapy Raises €2.6M in Series A Extension Financing

– PEP-Therapy, a biotechnology company based in Paris, raised €3m in Series A funding. – The funding was led by Anaxago, i&i Prague and BADGE as well as a €1m loan from Bpifrance. – The company intends to use the funds to finance the Phase I a/b clinical trial of PEP-010, its lead candidate, for the treatment of advanced solid tumors.